IBDEI21B ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,32473,1,4,0)
;;=4^H35.041
;;^UTILITY(U,$J,358.3,32473,2)
;;=^5005594
;;^UTILITY(U,$J,358.3,32474,0)
;;=H35.042^^128^1661^29
;;^UTILITY(U,$J,358.3,32474,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32474,1,3,0)
;;=3^Retinal Micro-Aneurysms,Unspec,OS
;;^UTILITY(U,$J,358.3,32474,1,4,0)
;;=4^H35.042
;;^UTILITY(U,$J,358.3,32474,2)
;;=^5005595
;;^UTILITY(U,$J,358.3,32475,0)
;;=H35.053^^128^1661^33
;;^UTILITY(U,$J,358.3,32475,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32475,1,3,0)
;;=3^Retinal Neovascularization,Unspec,OU
;;^UTILITY(U,$J,358.3,32475,1,4,0)
;;=4^H35.053
;;^UTILITY(U,$J,358.3,32475,2)
;;=^5005600
;;^UTILITY(U,$J,358.3,32476,0)
;;=H35.051^^128^1661^31
;;^UTILITY(U,$J,358.3,32476,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32476,1,3,0)
;;=3^Retinal Neovascularization,Unspec,OD
;;^UTILITY(U,$J,358.3,32476,1,4,0)
;;=4^H35.051
;;^UTILITY(U,$J,358.3,32476,2)
;;=^5005598
;;^UTILITY(U,$J,358.3,32477,0)
;;=H35.052^^128^1661^32
;;^UTILITY(U,$J,358.3,32477,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32477,1,3,0)
;;=3^Retinal Neovascularization,Unspec,OS
;;^UTILITY(U,$J,358.3,32477,1,4,0)
;;=4^H35.052
;;^UTILITY(U,$J,358.3,32477,2)
;;=^5005599
;;^UTILITY(U,$J,358.3,32478,0)
;;=H35.073^^128^1661^36
;;^UTILITY(U,$J,358.3,32478,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32478,1,3,0)
;;=3^Retinal Telangiectasis,OU
;;^UTILITY(U,$J,358.3,32478,1,4,0)
;;=4^H35.073
;;^UTILITY(U,$J,358.3,32478,2)
;;=^5005608
;;^UTILITY(U,$J,358.3,32479,0)
;;=H35.071^^128^1661^34
;;^UTILITY(U,$J,358.3,32479,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32479,1,3,0)
;;=3^Retinal Telangiectasis,OD
;;^UTILITY(U,$J,358.3,32479,1,4,0)
;;=4^H35.071
;;^UTILITY(U,$J,358.3,32479,2)
;;=^5005606
;;^UTILITY(U,$J,358.3,32480,0)
;;=H35.072^^128^1661^35
;;^UTILITY(U,$J,358.3,32480,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32480,1,3,0)
;;=3^Retinal Telangiectasis,OS
;;^UTILITY(U,$J,358.3,32480,1,4,0)
;;=4^H35.072
;;^UTILITY(U,$J,358.3,32480,2)
;;=^5005607
;;^UTILITY(U,$J,358.3,32481,0)
;;=H34.03^^128^1661^23
;;^UTILITY(U,$J,358.3,32481,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32481,1,3,0)
;;=3^Transient Retinal Artery Occlusion,OU
;;^UTILITY(U,$J,358.3,32481,1,4,0)
;;=4^H34.03
;;^UTILITY(U,$J,358.3,32481,2)
;;=^5005555
;;^UTILITY(U,$J,358.3,32482,0)
;;=H34.01^^128^1661^21
;;^UTILITY(U,$J,358.3,32482,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32482,1,3,0)
;;=3^Transient Retinal Artery Occlusion,OD
;;^UTILITY(U,$J,358.3,32482,1,4,0)
;;=4^H34.01
;;^UTILITY(U,$J,358.3,32482,2)
;;=^5005553
;;^UTILITY(U,$J,358.3,32483,0)
;;=H34.02^^128^1661^22
;;^UTILITY(U,$J,358.3,32483,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32483,1,3,0)
;;=3^Transient Retinal Artery Occlusion,OS
;;^UTILITY(U,$J,358.3,32483,1,4,0)
;;=4^H34.02
;;^UTILITY(U,$J,358.3,32483,2)
;;=^5005554
;;^UTILITY(U,$J,358.3,32484,0)
;;=H35.00^^128^1661^47
;;^UTILITY(U,$J,358.3,32484,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32484,1,3,0)
;;=3^Background Retinopathy,Unspec
;;^UTILITY(U,$J,358.3,32484,1,4,0)
;;=4^H35.00
;;^UTILITY(U,$J,358.3,32484,2)
;;=^5005581
;;^UTILITY(U,$J,358.3,32485,0)
;;=H34.823^^128^1661^50
;;^UTILITY(U,$J,358.3,32485,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32485,1,3,0)
;;=3^Venous Engorgement,OU
;;^UTILITY(U,$J,358.3,32485,1,4,0)
;;=4^H34.823
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI21B 3761 printed Apr 09, 2024@21:19:22 Page 2
IBDEI21B ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,32473,1,4,0)
+2 ;;=4^H35.041
+3 ;;^UTILITY(U,$J,358.3,32473,2)
+4 ;;=^5005594
+5 ;;^UTILITY(U,$J,358.3,32474,0)
+6 ;;=H35.042^^128^1661^29
+7 ;;^UTILITY(U,$J,358.3,32474,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,32474,1,3,0)
+10 ;;=3^Retinal Micro-Aneurysms,Unspec,OS
+11 ;;^UTILITY(U,$J,358.3,32474,1,4,0)
+12 ;;=4^H35.042
+13 ;;^UTILITY(U,$J,358.3,32474,2)
+14 ;;=^5005595
+15 ;;^UTILITY(U,$J,358.3,32475,0)
+16 ;;=H35.053^^128^1661^33
+17 ;;^UTILITY(U,$J,358.3,32475,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,32475,1,3,0)
+20 ;;=3^Retinal Neovascularization,Unspec,OU
+21 ;;^UTILITY(U,$J,358.3,32475,1,4,0)
+22 ;;=4^H35.053
+23 ;;^UTILITY(U,$J,358.3,32475,2)
+24 ;;=^5005600
+25 ;;^UTILITY(U,$J,358.3,32476,0)
+26 ;;=H35.051^^128^1661^31
+27 ;;^UTILITY(U,$J,358.3,32476,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,32476,1,3,0)
+30 ;;=3^Retinal Neovascularization,Unspec,OD
+31 ;;^UTILITY(U,$J,358.3,32476,1,4,0)
+32 ;;=4^H35.051
+33 ;;^UTILITY(U,$J,358.3,32476,2)
+34 ;;=^5005598
+35 ;;^UTILITY(U,$J,358.3,32477,0)
+36 ;;=H35.052^^128^1661^32
+37 ;;^UTILITY(U,$J,358.3,32477,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,32477,1,3,0)
+40 ;;=3^Retinal Neovascularization,Unspec,OS
+41 ;;^UTILITY(U,$J,358.3,32477,1,4,0)
+42 ;;=4^H35.052
+43 ;;^UTILITY(U,$J,358.3,32477,2)
+44 ;;=^5005599
+45 ;;^UTILITY(U,$J,358.3,32478,0)
+46 ;;=H35.073^^128^1661^36
+47 ;;^UTILITY(U,$J,358.3,32478,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,32478,1,3,0)
+50 ;;=3^Retinal Telangiectasis,OU
+51 ;;^UTILITY(U,$J,358.3,32478,1,4,0)
+52 ;;=4^H35.073
+53 ;;^UTILITY(U,$J,358.3,32478,2)
+54 ;;=^5005608
+55 ;;^UTILITY(U,$J,358.3,32479,0)
+56 ;;=H35.071^^128^1661^34
+57 ;;^UTILITY(U,$J,358.3,32479,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,32479,1,3,0)
+60 ;;=3^Retinal Telangiectasis,OD
+61 ;;^UTILITY(U,$J,358.3,32479,1,4,0)
+62 ;;=4^H35.071
+63 ;;^UTILITY(U,$J,358.3,32479,2)
+64 ;;=^5005606
+65 ;;^UTILITY(U,$J,358.3,32480,0)
+66 ;;=H35.072^^128^1661^35
+67 ;;^UTILITY(U,$J,358.3,32480,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,32480,1,3,0)
+70 ;;=3^Retinal Telangiectasis,OS
+71 ;;^UTILITY(U,$J,358.3,32480,1,4,0)
+72 ;;=4^H35.072
+73 ;;^UTILITY(U,$J,358.3,32480,2)
+74 ;;=^5005607
+75 ;;^UTILITY(U,$J,358.3,32481,0)
+76 ;;=H34.03^^128^1661^23
+77 ;;^UTILITY(U,$J,358.3,32481,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,32481,1,3,0)
+80 ;;=3^Transient Retinal Artery Occlusion,OU
+81 ;;^UTILITY(U,$J,358.3,32481,1,4,0)
+82 ;;=4^H34.03
+83 ;;^UTILITY(U,$J,358.3,32481,2)
+84 ;;=^5005555
+85 ;;^UTILITY(U,$J,358.3,32482,0)
+86 ;;=H34.01^^128^1661^21
+87 ;;^UTILITY(U,$J,358.3,32482,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,32482,1,3,0)
+90 ;;=3^Transient Retinal Artery Occlusion,OD
+91 ;;^UTILITY(U,$J,358.3,32482,1,4,0)
+92 ;;=4^H34.01
+93 ;;^UTILITY(U,$J,358.3,32482,2)
+94 ;;=^5005553
+95 ;;^UTILITY(U,$J,358.3,32483,0)
+96 ;;=H34.02^^128^1661^22
+97 ;;^UTILITY(U,$J,358.3,32483,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,32483,1,3,0)
+100 ;;=3^Transient Retinal Artery Occlusion,OS
+101 ;;^UTILITY(U,$J,358.3,32483,1,4,0)
+102 ;;=4^H34.02
+103 ;;^UTILITY(U,$J,358.3,32483,2)
+104 ;;=^5005554
+105 ;;^UTILITY(U,$J,358.3,32484,0)
+106 ;;=H35.00^^128^1661^47
+107 ;;^UTILITY(U,$J,358.3,32484,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,32484,1,3,0)
+110 ;;=3^Background Retinopathy,Unspec
+111 ;;^UTILITY(U,$J,358.3,32484,1,4,0)
+112 ;;=4^H35.00
+113 ;;^UTILITY(U,$J,358.3,32484,2)
+114 ;;=^5005581
+115 ;;^UTILITY(U,$J,358.3,32485,0)
+116 ;;=H34.823^^128^1661^50
+117 ;;^UTILITY(U,$J,358.3,32485,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,32485,1,3,0)
+120 ;;=3^Venous Engorgement,OU
+121 ;;^UTILITY(U,$J,358.3,32485,1,4,0)
+122 ;;=4^H34.823
